Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
DU ›
DUETRE
Trademark search for:
DUETRE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-11-08 — Application filed
2017-11-11 — Application filed
2017-11-17 — Application filed
2018-02-21 — Assigned to examiner
2018-02-21 — Final disposition recorded
2018-02-21 — Final disposition recorded
2018-02-21 — Final disposition recorded
2018-07-26 — Office action issued
2018-07-26 — Correspondence received in law office
2018-07-26 — Teas/email correspondence entered
2018-08-08 — Final disposition recorded
2018-08-08 — Final disposition recorded
2018-08-08 — Final disposition recorded
2018-12-12 — Office action issued
2018-12-12 — Correspondence received in law office
2018-12-12 — Teas/email correspondence entered
2018-12-14 — Examiners amendment -written
2018-12-14 — Examiner's amendment entered
2018-12-14 — Examiners amendment e-mailed
2018-12-14 — Notification of examiners amendment e-mailed
2018-12-14 — Approved for pub - principal register
2019-01-23 — Notification of notice of publication e-mailed
2019-02-12 — Published for opposition
2019-02-12 — Official gazette publication confirmation e-mailed
2019-04-09 — Noa e-mailed - sou required from applicant
2019-10-04 — Sou teas extension received
2019-10-04 — Sou extension 1 filed
2019-10-04 — Sou extension 1 granted
2019-10-04 — Teas change of correspondence received
2019-10-08 — Notice of approval of extension request e-mailed
2020-04-06 — Sou teas extension received
2020-04-06 — Sou extension 2 filed
2020-04-06 — Sou extension 2 granted
2020-04-08 — Notice of approval of extension request e-mailed
2020-10-01 — Sou teas extension received
2020-10-01 — Sou extension 3 filed
2020-10-01 — Sou extension 3 granted
2020-10-03 — Notice of approval of extension request e-mailed
2021-05-10 — Application abandoned
2021-05-10 — Application abandoned
2021-05-10 — Final status recorded
Owner Information
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc.
Correspondent
Teva Pharmaceuticals USA, Inc.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
